Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy.
Bioorganic & medicinal chemistry letters 2009 Nov 3; In press
Velcicky J, Feifel R, Hawtin S, Heng R, Huppertz C, Koch G, Kroemer M, Moebitz H, Revesz L, Scheufler C, Schlapbach A
Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.
New, selective 3-aminopyrazole based MK2-inhibitors were discovered by scaffold hopping strategy. The new derivatives proved to inhibit intracellular phosphorylation of hsp27 as well as LPS-induced TNFalpha release in cells. In addition, selected derivative 14e also inhibited LPS-induced TNFalpha release in vivo.
Keywords: MK-2
